Cas:74124-88-2 5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene manufacturer & supplier

Chemical Name:5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene

CAS.NO:74124-88-2

Synonyms:5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene

Molecular Formula:C₉H₇ClO

Molecular Weight:166.60400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:12.53000

Exact Mass:166.01900

LogP:2.33600

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene Use and application,5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene technical grade,usp/ep/jp grade.

Related News: Although bird flu poses more of a danger to poultry than humans �� it is not easily transmissible among people �� the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic. 5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene manufacturer Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. 5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene supplier Although bird flu poses more of a danger to poultry than humans �� it is not easily transmissible among people �� the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic. 5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene vendor ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 5-chloro-6,6a-dihydro-1aH-indeno[1,2-b]oxirene factory In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements.